Report Highlights
The global market for microelectronic medical implants is expected to grow from $49.0 billion in 2024 and is projected to reach $85.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2024 to 2029.
Report Includes
- 64 data tables and 30 additional tables
- An overview of the global market for microelectronic medical implants
- Analysis of global market trends, featuring historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2029, and projected CAGRs through 2029
- Evaluation of the current market size and revenue growth prospects, along with market share analysis by product type, application, and geographic region
- Discussion of innovations, technological advances, and product launches
- Analysis of the industry’s regulatory framework and policies
- A look at the product pipeline
- Discussion of ESG practices of companies in the industry, and the ESG challenges facing them
- Analysis of the leading companies’ market shares, proprietary technologies, and strategic alliances
- Evaluation of key patents
- Profiles of the leading players, including Abbott, Cochlear Ltd., LivaNova PLC, Medtronic, and NEVRO CORP.
Report Scope
This report analyzes the trends in the global and regional markets for microelectronic medical implants with data from 2023, estimates from 2024, and projections of compound annual growth rates (CAGRs) for the forecast period of 2024 to 2029. This report also analyzes the competitive environment, including the market shares of leading companies, the regulatory scenario, and the drivers, restraints and opportunities in the market.
The market in this report is segmented into product types and applications. Product types include pacemakers, defibrillators, neurostimulators, hearing implants, ocular implants, and others. Applications includes cardiology, neurology, audiology, ophthalmology, and others.
The market is segmented into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). The regional analysis include coverage of the markets in the U.S., Germany, the U.K., France, Japan, China, and India. The market value is estimated for 2023, with forecasts for 2024 and 2029.
The report’s goals are to:
- Analyze main implant types and applications.
- Analyze global market size and segmentation.
- Understand market constraints and drivers.
- Provide detailed market forecasts up to 2029.
- Assess market shares, competitiveness, and industry structure.
- Identify potential long-term impacts on the microelectronic implants industry
Report Synopsis
| Report Metrics | Details | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||
| Forecast period considered | 2024-2029 | ||||||||||
| Base year market size | $44.1 billion | ||||||||||
| Market size forecast | $85.1 billion | ||||||||||
| Growth rate | CAGR of 11.7% for the forecast period of 2024-2029 | ||||||||||
| Units considered | $ Millions | ||||||||||
| Segments covered | Product Type, Application, and Region | ||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||
| Countries covered | China, India, Japan, U.S., Canada, Mexico, Germany, U.K., Italy, and France | ||||||||||
| Key Market Drivers |
|
||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Consulting Editor’s Credentials
Melissa Dueck brings more than 25 years of health industry experience to the consulting analyst role with expertise in pharmaceuticals, medical technologies, and hospital operations. Ms. Dueck holds an MBA in Health Care Management, an MPH in Global Health, and is a pending doctoral candidate. She has authored several industry-specific documents and is a well-respected, trusted contributor to the market intelligence community. Her writings are published in magazines, newspapers, and professional journals. She is also an experienced custom market research writer who has worked with a large variety of clients in many fields who require innumerable variations to research documents. Ms. Dueck serves the health and medical community through emergency room medical training, healthcare information system coordination, program implementation and evaluations, and strategic business oversight planning.
Report Highlights
The global market for microelectronic medical implants should reach over $37.6 billion in 2021 from over $24.6 billion in 2016 at a compound annual growth rate (CAGR) of 8.8% from 2016 to 2021.
Report Includes
- An overview of the global markets and technologies for microelectronic medical implants.
- An analysis of global market trends, with data from 2015, 2016 and projections of compound annual growth rates (CAGRs) through 2021.
- Major implant types and applications, both commercial and developmental.
- Global market size and segmentation, including historical data on sales by application and implant type.
- Market drivers and constraints.
- A look at industry structure, competition and market shares.
- Factors that may influence the long-term market for microelectronic implants.
- Profiles of major players in the industry.
Report Highlights
The global market for microelectronic medical implants, accessories, and supplies was worth an estimated $15.4 billion in 2010. The market is projected to grow to $16.3 billion in 2011 and $24.8 billion in 2016, a compound annual growth rate (CAGR) of 8.8%, between 2011 and 2016.
Report Highlights
-
The global market for microelectronic medical implants was worth an estimated $11.7 billion in 2006. The market is projected to grow to $12.6 billion in 2007 and $22.1 billion in 2012 at a CAGR of 11.9% from 2007 to 2012.
-
Cardiac implants were by far the largest market segment in 2006, accounting for more than three-quarters of total implant sales. Neurostimulators were the second largest market segment, with about 9% of the market, followed by accessories such as leads and electrodes, with a 7% market share. executive summary (Continued)
-
However, the market for neurostimulators is projected to grow over twice as fast as the market for cardiac implants from 2007 to 2012, that is, at a CAGR of 20% vs. 10% respectively.
Report Highlights
-
The global market for microelectronic medical implants is projected to be $11.9 billion in 2004 and to rise at an average annual growth rate (AAGR) of 22.1% to $32.3 billion in 2009.
-
Cardiac implants by far were the largest market segment in 2003, with sales of $7.2 billion, or more than three-quarters of total sales.
-
Neurostimulators were the second largest market segment, with sales of $944 million, but are projected to grow at an AAGR of 39.7%, more than double that of cardiac implants (18.4%).
-
The AAGR for accessories and supplies (27.5%) also is expected to outstrip growth of the market as a whole. The slowest-growing market segments likely will be spinal fusion stimulators and implantable drug pumps.
- Eye implants are unlikely to see any commercial sales before 2009.
Related Reports
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Global Markets for Drug-Device Combinations
The global market for drug-device combinations is expected to grow from $129.4 billion in 2024 and is projected to reach $199.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2024 to 2029.
Global Markets and Technologies for Advanced Drug Delivery Systems
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More